home / stock / axsm / axsm news


AXSM News and Press, Axsome Therapeutics Inc. From 07/05/23

Stock Information

Company Name: Axsome Therapeutics Inc.
Stock Symbol: AXSM
Market: NASDAQ
Website: axsome.com

Menu

AXSM AXSM Quote AXSM Short AXSM News AXSM Articles AXSM Message Board
Get AXSM Alerts

News, Short Squeeze, Breakout and More Instantly...

AXSM - ARV, AXSM and OMER are among after hour movers

2023-07-05 17:32:16 ET Gainers: Cardlytics, Inc. ( NASDAQ: CDLX ) +9% . Autolus Therapeutics  ( AUTL ) +5% . Omeros ( OMER ) +4% . Arrival ( ARVL ) +3% . Nkarta ( NKTX ) +3% . Losers: IDEAYA Biosciences ( IDYA ...

AXSM - Rally Turned Around From A Shallow Sell-Off Last Week, What's Next?

2023-07-02 23:54:27 ET Summary It's great to write a weekly article about market conditions. It's just that when Monday comes along and presents a new set of information, my tactics must change. Yes, I saw that finally there would be selling. Yet, being in a down market is never a...

AXSM - 5 Top Stocks for July

2023-07-01 05:45:00 ET In today's complicated market, it can be difficult to filter out the noise and focus on what matters most -- achieving your financial goals. The best way to do that is by selecting top stocks and then building a diversified portfolio of companies that you believe can ...

AXSM - Axsome Therapeutics Announces Closing of Public Offering of $225 Million of Shares of Common Stock

NEW YORK, June 30, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM) (“Axsome” or the “Company”), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced the clo...

AXSM - Sage Therapeutics: Zuranolone August Approval Likely, Opportunity Uncertain

2023-06-30 13:15:02 ET Summary Sage Therapeutics, Inc. should find out in August whether its drug targeting major depressive disorder and postpartum depression, zuranolone, will be approved. Zuranolone is being co-developed with Biogen, who made an upfront payment to Sage of $1.5b...

AXSM - Why Shares of Axsome Therapeutics Fell Wednesday

2023-06-28 15:59:02 ET Shares of Axsome Therapeutics (NASDAQ: AXSM) were down more than 10% as of 3:45 p.m. ET Wednesday after the company announced it is offering 3 million shares at $75 each in a stock sale worth $225 million. The stock is down more than 3% this year. The bi...

AXSM - Axsome Therapeutics prices discounted stock offering to raise $225M, shares fall

2023-06-28 14:24:47 ET Axsome Therapeutics ( NASDAQ: AXSM ) on Wednesday priced a public offering of its common shares to raise $225 million. The company said it will offer 3 million shares at $75 apiece. The offer price represents a 10% discount to the stock's c...

AXSM - Minerva, Regional Health top healthcare gainers; Cognition, Eton among losers

2023-06-28 10:09:16 ET Gainers: Minerva Neurosciences ( NERV ) +51% . Regional Health Properties ( RHE ) +12% . Genfit ( GNFT ) +11% . RenovoRx ( RNXT ) +11% . OPKO Health ( OPK ) +5% . Losers: Cognition Therapeutics ( C...

AXSM - Axsome Therapeutics Announces Pricing of Public Offering of $225 Million of Shares of Common Stock

NEW YORK, June 28, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM) (“Axsome” or the “Company”), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced the pri...

AXSM - As the Bull Roars, Shareholders Hate How These 2 Companies Are Selling Their Stock

2023-06-28 09:25:19 ET The stock market has treated investors well so far in 2023, and although the past couple of weeks have been a bit more turbulent, the Nasdaq Composite (NASDAQINDEX: ^IXIC) gave Wall Street a gain of more than 1.5% on Tuesday. Wednesday morning looks a bit less...

Previous 10 Next 10